Hospital News and Research

RSS

Researchers discover RAF oncogene that may drive aggressive forms of prostate cancer

The Prostate Cancer Foundation announced today that researchers at the University of Michigan Comprehensive Cancer Center have discovered the RAF oncogene that drives fatal melanomas may also drive the aggressive forms of prostate cancer in the clinic.

8 Jun 2010

Gail Donner receives Jeanne Mance Award for her positive impact on practice of nursing in Canada

Gail Donner will receive Canada's most prestigious nursing award, the Jeanne Mance Award, for her positive impact on the practice of nursing in Canada.

8 Jun 2010

Interim results from Micromet's MT110 BiTE antibody Phase 1 trial presented at ASCO

Micromet, Inc., a biopharmaceutical company focused on the development and commercialization of next-generation antibodies for the treatment of cancer, today announced the presentation of updated interim results from a Phase 1 trial of the Company's BiTE antibody MT110 in patients with advanced solid tumors.

8 Jun 2010

Rice University students develop new device to help children with acute respiratory infections

Gently, gently. That's how babies should be handled, and it was the prime consideration when a team of Rice University seniors developed a device that could save babies' lives.

8 Jun 2010

Tenet Healthcare withdraws from preliminary discussions regarding potential acquisition of Healthscope

Tenet Healthcare Corporation today announced it has withdrawn from preliminary discussions regarding a potential acquisition of the Australian private hospital operator Healthscope Limited. Due to the sequence of events associated with the acquisition process, including the premature disclosure of non-public information regarding Tenet's preliminary interest in Healthscope, Tenet has been unable to complete the work necessary to thoroughly convey to shareholders the potential value, including the inherent risks and opportunities, of this transaction.

8 Jun 2010

Greatbatch celebrates 50th anniversary of first successful US human cardiac pacemaker implantation

Greatbatch, Inc. is proud to join the medical community in celebrating the 50th anniversary of the first successful implantation of the human cardiac pacemaker in the United States. The pacemaker was designed, developed and implanted by Wilson Greatbatch in conjunction with William M. Chardack, M.D. and Andrew A. Gage, M.D.

8 Jun 2010

SHS exposure associated with psychological distress, risk of future psychiatric illness: UCL research

Second hand smoke exposure is associated with psychological distress and risk of future psychiatric illness, according to new UCL research that suggests the harmful affects of passive smoking go beyond physical health.

8 Jun 2010

Hospira signs licensing agreement to develop and market DURECT's POSIDUR

Hospira, Inc., a global specialty pharmaceutical and medication delivery company, and DURECT Corporation, a specialty pharmaceutical company, today announced that the companies have entered into a licensing agreement to develop and market DURECT's POSIDUR (SABER-bupivacaine) a long-acting version of the anesthetic bupivacaine currently in Phase III clinical trials.

8 Jun 2010

U.S. Renal Care acquires Dialysis Corporation of America for $110.25M

U.S. Renal Care, Inc., a leading privately-held provider of outpatient dialysis services, today announced that it has completed its $110.25 million acquisition of Dialysis Corporation of America, Inc., a leading provider of outpatient kidney dialysis services. With this acquisition, USRC will provide dialysis services to approximately 5,500 patients and operate 84 dialysis centers, home and specialty hospital dialysis programs and facilities in nine states: Arkansas, Georgia, Maryland, New Jersey, Ohio, Pennsylvania, South Carolina, Texas, and Virginia.

8 Jun 2010

Lawsuit to be launched over breast cancer gene patent

BRCA1 and BRCA2 are two genes that have been identified to hold a key to women’s susceptibility to get breast or ovarian cancer. Changes also known as mutations in these genes are significant in women who go on to develop breast or ovarian cancer. Melbourne-based company Genetic Technologies Limited (GTL) has the exclusive license from American biotechnology company Myriad Genetics to carry out testing for the genes in Australia. Myriad holds a patent for these genes.

7 Jun 2010

MHRA issues Supplementary Accreditation to Chiltern

Chiltern International Limited, a global contract research organization, has announced that Chiltern Early Phase Limited, based in Ninewells Hospital and Medical School in Dundee, Scotland, has achieved Supplementary Accreditation from the Medicines and Healthcare products Regulatory Agency.

7 Jun 2010

Masimo announces full market release of Rainbow Acoustic Monitoring to provide RRa

Masimo, the inventor of Pulse CO-Oximetry and Measure-Through Motion and Low Perfusion pulse oximetry, announced today the full market release of its latest medical technology breakthrough—Masimo Rainbow Acoustic Monitoring— providing continuous and noninvasive respiration rate that is accurate, easy-to-use, and enhances patient tolerance.

7 Jun 2010

Oslo University Hospital, Induct announce long term strategic partnership Agreement

Oslo University Hospital and Induct Software AS, "The Open Innovation Company," today announced a long term strategic partnership Agreement under which the parties will work together to help Oslo University Hospital achieve its goal of becoming the world leader in healthcare innovation.

7 Jun 2010

UBMD selects Allscripts EHR solution to help its physicians enhance quality of patient care

Allscripts announced today that UBMD has selected the Allscripts Electronic Health Record solution to help its 450 physicians enhance the quality of patient care, improve patient communications, and better manage the cost of care delivery.

7 Jun 2010

Watermark Medical completes $15M equity investment from CA Technologies

Watermark Medical, Inc., a privately-held medical products and services company currently servicing the sleep-disordered breathing market, today announced the completion of a $15 million equity investment from CA Technologies. This equity investment in Watermark Medical represents CA Technologies' entry into the emerging Software-as-a-Service -based healthcare cloud market.

7 Jun 2010

XCell-Center GmbH announces approval of clinical trial in patients with chronic spinal cord injury

XCell-Center GmbH, Europe's leading provider of adult autologous stem cell therapy, announced approval of the first placebo controlled double blind clinical trial in patients with chronic spinal cord injury.

7 Jun 2010

Angiochem presents positive Phase 1/2 clinical data of ANG1005 for brain cancer at ASCO 2010

Angiochem, Inc., a clinical-stage biotechnology company developing drugs that are uniquely capable of crossing the blood-brain barrier (BBB) through LRP-1 targeting, announced today that complete phase 1/2 clinical data in two clinical studies of its lead oncology program, ANG1005, for the treatment of brain cancers, including glioblastoma (GBM) and brain metastases, were presented at the 2010 American Society for Clinical Oncology (ASCO) Annual Meeting, June 4-8, in Chicago, IL.

7 Jun 2010

Alnylam presents interim data from ALN-VSP02 Phase I trial for liver cancer at ASCO 2010

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today preliminary clinical data from its ongoing Phase I trial with ALN-VSP, a systemically delivered RNAi therapeutic for the treatment of advanced solid tumors with liver involvement.

7 Jun 2010

SEMHIE wins $3M contract for Social Security Administration's electronic medical records initiative

The Southeast Michigan Health Information Exchange announced today that it has won a $2,988,000 contract for an electronic medical records initiative from the Social Security Administration. This award comes to SEMHIE in partnership with its fiduciary, Southeastern Michigan Health Association and its project partners CNSI, The Object Management Group™, Computer Sciences Corporation and Oracle/Sun Microsystems.

7 Jun 2010

Clivatuzumab tetraxetan shows promising results in patients with metastatic pancreatic cancer

Immunomedics, Inc., a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today announced that its proprietary antibody, clivatuzumab tetraxetan, labeled with yttrium-90 plus low-dose gemcitabine continues to produce promising efficacy results in patients with previously untreated, inoperable, locally advanced or metastatic pancreatic cancer.

7 Jun 2010

Hospital News and Research

Researchers discover RAF oncogene that may drive aggressive forms of prostate cancer

Gail Donner receives Jeanne Mance Award for her positive impact on practice of nursing in Canada

Interim results from Micromet's MT110 BiTE antibody Phase 1 trial presented at ASCO

Rice University students develop new device to help children with acute respiratory infections

Tenet Healthcare withdraws from preliminary discussions regarding potential acquisition of Healthscope

Greatbatch celebrates 50th anniversary of first successful US human cardiac pacemaker implantation

SHS exposure associated with psychological distress, risk of future psychiatric illness: UCL research

Hospira signs licensing agreement to develop and market DURECT's POSIDUR

U.S. Renal Care acquires Dialysis Corporation of America for $110.25M

Lawsuit to be launched over breast cancer gene patent

MHRA issues Supplementary Accreditation to Chiltern

Masimo announces full market release of Rainbow Acoustic Monitoring to provide RRa

Oslo University Hospital, Induct announce long term strategic partnership Agreement

UBMD selects Allscripts EHR solution to help its physicians enhance quality of patient care

Watermark Medical completes $15M equity investment from CA Technologies

XCell-Center GmbH announces approval of clinical trial in patients with chronic spinal cord injury

Angiochem presents positive Phase 1/2 clinical data of ANG1005 for brain cancer at ASCO 2010

Alnylam presents interim data from ALN-VSP02 Phase I trial for liver cancer at ASCO 2010

SEMHIE wins $3M contract for Social Security Administration's electronic medical records initiative

Clivatuzumab tetraxetan shows promising results in patients with metastatic pancreatic cancer

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Latest News